Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study

Clinical trial NCT03895502 · COMPLETED

Trial details

NCT number: NCT03895502
Sponsor: Takeshi Morimoto
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Venous Thrombosis Neoplasms Anticoagulant

Start date: 2019-05-27
Primary completion: 2023-06-30
Enrollment: 605

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.